MELLYCAR VALENTON: Open Payments
NPI 1164000790 · NORWALK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 10 payments from 9 companies in 2025. Trend: 2023 $664 · 2024 $270 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $122 |
| PFIZER INC. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| BeOne Medicines USA, Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Tempus AI, Inc | 1 | $22 |
| SOBI, INC | 1 | $17 |
| Incyte Corporation | 1 | $16 |
Products named: RYBREVANT, ELREXFIO, CALQUENCE, OJJAARA, BRUKINSA, LYNOZYFIC, XT CDX, Vonjo.
Industry payments across CT — which companies pay providers there.
